Oct 30, 2019
This week's View offers key points to remember from an opinion article on the current diagnostic criteria and differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and a consensus statement on the diagnosis of heart failure (HF) with preserved ejection fraction (EF) and also addresses how sacubitril/valsartan impacts certain biomarker levels compared with enalapril in patients with HF and reduced EF.